Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	90.38	30.84	16.20
Graham Fair Price	165.00	5158.78	1946.70
PEG	227.22	< 0.005	< 0.005
Price/Book	16.30	0.66	0.56
Price/Cash Flow	-81.71	8.69	47.49
Prices/Earnings	-87.67	-0.86	6.96
Price/Sales	17.56	0.77	0.65
Price/FCF	-81.71	8.69	47.49
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-16.56	0.14	0.16
Operating Margin	-93.27	< 0.005	0.03
ROA	835.62	-0.10	0.01
ROE	0.02	-0.19	842.96
ROIC	0.02	< 0.005	-92.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.17	< 0.005	14492.37
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	2.42	-1.06	-56.25
EPS QOQ	242.42	-9.14	-96.23
FCF QOQ	2.28	4.50	97.86
Revenue QOQ	0.07	-0.14	111.48
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.83	36.60	2.15
Days Sales Outstanding (DSO)	48.96	47.64	-2.70
Inventory Turnover	2.51	2.46	-2.11
Debt/Capitalization	0.24	0.23	-4.71
Quick Ratio	0.78	0.82	5.26
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2883.12	2488.08	-13.70
Cash	383.34	387.92	1.19
Capex	-33.96	-27.00	20.48
Free Cash Flow	34.24	187.90	448.80
Revenue	2486.02	2122.55	-14.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.18	1.25	6.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.73	7.02	48.45
Naive Interpretation	Member

06 - Financial Health · Weak

Rating